Neos Therapeutics, Inc. NEOS

Neos Therapeutics, Inc. DIO Ratio 2011-2026 | NEOS

Annual DIO Ratio Neos Therapeutics, Inc.

2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	160	141	396	184	166	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
396	141	209

DIO Ratio of other stocks in the Biotechnology industry

	Issuer	DIO Ratio	Price	% 24h	Market Cap	Country
	Amphastar Pharmaceuticals AMPH	166	$ 21.65	-	$ 1.01 B	USA
	Midatech Pharma plc MTP	40.6	-	-18.52 %	$ 27.3 M	Britain
	Alexion Pharmaceuticals, Inc. ALXN	512	-	-	$ 40.3 B	USA
	Aptorum Group Limited APM	4.89	$ 0.9	-0.18 %	$ 6.62 M	China
	ACADIA Pharmaceuticals ACAD	295	$ 22.3	-	$ 3.7 B	USA
	BioDelivery Sciences International BDSI	321	-	-4.8 %	$ 255 M	USA
	CASI Pharmaceuticals CASI	47.4	-	-	$ 35.4 M	USA
	Институт стволовых клеток человека ISKJ	275	-	-	-	Russia
	ChromaDex Corporation CDXC	69.7	-	-0.88 %	$ 598 M	USA
	Aeterna Zentaris AEZS	55.6	-	5.93 %	$ 314 M	Canada
	Heron Therapeutics HRTX	644	$ 1.19	-	$ 198 M	USA
	Aquestive Therapeutics AQST	120	$ 4.1	-	$ 438 M	USA
	Arcutis Biotherapeutics ARQT	185	$ 23.42	-	$ 2.98 B	USA
	ImmuCell Corporation ICCC	185	$ 8.25	-	$ 74.5 M	USA
	Autolus Therapeutics plc AUTL	70.7	$ 1.42	-	$ 378 M	Britain
	AstraZeneca PLC AZN	206	-	-	$ 96.9 B	Britain
	BeiGene, Ltd. BGNE	304	-	0.49 %	$ 251 B	Cayman-islands
	Kamada Ltd. KMDA	166	$ 8.2	-	$ 260 M	Israel